Pyrr, good idea for the re-listen. LP did say "about this trial and the data" regarding the ASCO submission. In fact, she mentioned data twice - she later said "... we won't be able to talk about the data between now and ASCO... but we are quite encouraged".
For me, this simply confirms what I already think: we will hear data at ASCO, and LPs body language suggests the data is very good.
I would also expect a PR on Sunday June 1 after 11:46am CST that reveals the data to anyone not attending, and that NW would highlight the data in their booth after this same time. And I would expect them to be on one or more of the financial news networks. These elements are marketing 101.